Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why are there no new antibiotics?

M J Pucci, T J Dougherty, J F Barrett

    Expert Opinion on Investigational Drugs
    |July 5, 2005
    PubMed
    Summary

    The pharmaceutical industry is renewing efforts to combat antibiotic-resistant pathogens by developing new discovery tools. These advancements aim to identify key targets in bacterial metabolism for novel antibiotic development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Do intraoperative pyloric interventions predict the need for postoperative endoscopic interventions after minimally invasive esophagectomy?

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
    Same author

    Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial.

    BJOG : an international journal of obstetrics and gynaecology·2015
    Same author

    Bacterial resistance.

    IDrugs : the investigational drugs journal·2005
    Same author

    Quinolone update.

    IDrugs : the investigational drugs journal·2005
    Same author

    Targets, targets everywhere--so where are the new antibacterial drugs?

    IDrugs : the investigational drugs journal·2005
    Same author

    American Society of Microbiology - 100th General Meeting.

    IDrugs : the investigational drugs journal·2005

    Area of Science:

    • Microbiology
    • Pharmacology
    • Biochemistry

    Background:

    • The rise of antibiotic-resistant pathogens presents a significant global health challenge.
    • Traditional antibiotic discovery pipelines face limitations in addressing novel resistance mechanisms.

    Discussion:

    • Novel tools and technologies are crucial for understanding bacterial metabolic pathways.
    • Identifying critical therapeutic intervention points can guide the development of effective antimicrobial agents.
    • Interdisciplinary approaches combining genomics, metabolomics, and drug discovery are essential.

    Key Insights:

    • Pharmaceutical companies are reinvesting in antibiotic research and development.
    • Advanced technologies are being utilized to explore bacterial metabolism for drug targets.
    • Focus is shifting towards understanding the metabolic vulnerabilities of resistant bacteria.

    Outlook:

    • Continued innovation in discovery platforms will accelerate the identification of new antibiotic candidates.
    • Targeting bacterial metabolism offers a promising strategy to overcome existing resistance.
    • Collaborative efforts between academia and industry are vital for future success in combating antimicrobial resistance.

    Related Experiment Videos